Estimating the global cost of vision impairment and its major causes: protocol for a systematic review

Ana Patricia Marques¹, Jacqueline Ramke^{2

3}, John Cairns⁴, Thomas Butt⁵, Justine H Zhang², Hannah B Faal⁶, Hugh Taylor⁷, Iain Jones⁸, Nathan Congdon^{9

10}, Andrew Bastawrous², Tasanee Braithwaite^{2

11}, Marty Jovic¹², Serge Resnikoff¹³, Allyala Nandakumar¹⁴, Peng Tee Khaw¹⁵, Rupert R A Bourne¹⁶, Iris Gordon², Kevin Frick¹⁷, Matthew J Burton^{2

11}

Affiliations

¹ International Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, UK Patricia.Marques@lshtm.ac.uk.
² International Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, UK.
³ School of Optometry and Vision Science, University of Auckland, Auckland, New Zealand.
⁴ Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
⁵ UCL Institute of Ophthalmology, University College London, London, UK.
⁶ Department of Ophthalmology, University of Calabar, Calabar, Nigeria.
⁷ University of Melbourne School of Population and Global Health, Melbourne, Victoria, Australia.
⁸ Sightsavers, Haywards Heath, UK.
⁹ Centre for Public Health, Queen's University, Belfast, UK.
¹⁰ Sun Yat-Sen University Zhongshan Ophthalmic Center, Guangzhou, Guangdong, China.
¹¹ Moorfields Eye Hospital, London, UK.
¹² PricewaterhouseCoopers, Sydney, New South Wales, Australia.
¹³ Brien Holden Vision Institute, University of New South Wales, Sydney, New South Wales, Australia.
¹⁴ Brandeis University Heller School for Social Policy and Management, Waltham, Massachusetts, USA.
¹⁵ NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK.
¹⁶ Vision and Eye Research Unit, Anglia Ruskin University, Cambridge, UK.
¹⁷ Johns Hopkins University Carey Business School - Baltimore Campus, Baltimore, Maryland, USA.

PMID: 32895273
PMCID: PMC7476478
DOI: 10.1136/bmjopen-2019-036689

Estimating the global cost of vision impairment and its major causes: protocol for a systematic review

Ana Patricia Marques et al. BMJ Open. 2020.

. 2020 Sep 6;10(9):e036689.

doi: 10.1136/bmjopen-2019-036689.

Authors

Affiliations

¹ International Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, UK Patricia.Marques@lshtm.ac.uk.
² International Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, UK.
³ School of Optometry and Vision Science, University of Auckland, Auckland, New Zealand.
⁴ Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
⁵ UCL Institute of Ophthalmology, University College London, London, UK.
⁶ Department of Ophthalmology, University of Calabar, Calabar, Nigeria.
⁷ University of Melbourne School of Population and Global Health, Melbourne, Victoria, Australia.
⁸ Sightsavers, Haywards Heath, UK.
⁹ Centre for Public Health, Queen's University, Belfast, UK.
¹⁰ Sun Yat-Sen University Zhongshan Ophthalmic Center, Guangzhou, Guangdong, China.
¹¹ Moorfields Eye Hospital, London, UK.
¹² PricewaterhouseCoopers, Sydney, New South Wales, Australia.
¹³ Brien Holden Vision Institute, University of New South Wales, Sydney, New South Wales, Australia.
¹⁴ Brandeis University Heller School for Social Policy and Management, Waltham, Massachusetts, USA.
¹⁵ NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK.
¹⁶ Vision and Eye Research Unit, Anglia Ruskin University, Cambridge, UK.
¹⁷ Johns Hopkins University Carey Business School - Baltimore Campus, Baltimore, Maryland, USA.

PMID: 32895273
PMCID: PMC7476478
DOI: 10.1136/bmjopen-2019-036689

Abstract

Introduction: Vision impairment (VI) places a burden on individuals, health systems and society in general. In order to support the case for investing in eye health services, an updated cost of illness study that measures the global impact of VI is necessary. To perform such a study, a systematic review of the literature is needed. Here we outline the protocol for a systematic review to describe and summarise the costs associated with VI and its major causes.

Methods and analysis: We will systematically search in Medline (Ovid) and the Centre for Reviews and Dissemination database which includes the National Health Service Economics Evaluation Database. No language or geographical restriction will be applied. Additional literature will be identified by reviewing the references in the included studies and by contacting field experts. Grey literature will be considered. The review will include any study published from 1 January 2000 to November 2019 that provides information about costs of illness, burden of disease and/or loss of well-being in participants with VI due to an unspecified cause or due to one of the seven leading causes globally.Two reviewers will independently screen studies and extract relevant data from included studies. Methodological quality of economic studies will be assessed based on the British Medical Journal checklist for economic submissions adapted to costs of illness studies. This protocol has been prepared following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis protocols and has been published prospectively in Open Science Framework.

Ethics and dissemination: Formal ethical approval is not required, as primary data will not be collected in this review. The findings of this study will be disseminated through peer-reviewed publications, stakeholder meetings and inclusion in the ongoing Lancet Global Health Commission on Global Eye Health. REGISTRATION DETAILS: https://osf.io/9au3w (DOI 10.17605/OSF.IO/6F8VM).

Keywords: health economics; ophthalmology; public health.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

1. Bourne RRA, Flaxman SR, Braithwaite T, et al. . Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health 2017;5:e888–97. 10.1016/S2214-109X(17)30293-0 - DOI - PubMed
1. Flaxman SR, Bourne RRA, Resnikoff S, et al. . Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health 2017;5:e1221–34. 10.1016/S2214-109X(17)30393-5 - DOI - PubMed
1. West SK, Rubin GS, Broman AT, et al. . How does visual impairment affect performance on tasks of everyday life? the see project. Salisbury eye evaluation. Arch Ophthalmol 2002;120:774–80. 10.1001/archopht.120.6.774 - DOI - PubMed
1. Rubin GS, Muñoz B, Bandeen-Roche K, et al. . Monocular versus binocular visual acuity as measures of vision impairment and predictors of visual disability. Invest Ophthalmol Vis Sci 2000;41:3327–34. - PubMed
1. Black AA, Wood JM, Lovie-Kitchin JE. Inferior visual field reductions are associated with poorer functional status among older adults with glaucoma. Ophthalmic Physiol Opt 2011;31:283–91. 10.1111/j.1475-1313.2010.00811.x - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

207472/Z/17/Z/WT_/Wellcome Trust/United Kingdom

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Estimating the global cost of vision impairment and its major causes: protocol for a systematic review

Affiliations

Estimating the global cost of vision impairment and its major causes: protocol for a systematic review

Authors

Affiliations

Abstract

Conflict of interest statement

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources